Date published: 2025-11-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

TAF II p170 Inhibitors

TAF II p170 inhibitors are a class of chemical compounds that target the transcription-associated factor II p170 (TAF II p170), a component of the transcription factor IID (TFIID) complex. TAF II p170 plays a critical role in the regulation of gene transcription by acting as a co-activator in the assembly of the transcription pre-initiation complex. This protein is involved in the recognition of promoter regions of genes and helps to recruit RNA polymerase II to initiate transcription. TAF II p170 interacts with both the TATA-binding protein (TBP) and other TAFs within the TFIID complex, making it essential for the proper regulation of gene expression in eukaryotic cells. Inhibitors of TAF II p170 disrupt its function within the TFIID complex, thereby affecting the transcriptional machinery's ability to initiate and regulate the expression of specific genes.

The mechanism of action for TAF II p170 inhibitors generally involves binding to key domains of the protein, preventing it from interacting with other components of the transcription machinery, such as TBP or RNA polymerase II. By interfering with these interactions, TAF II p170 inhibitors block the formation of the transcription pre-initiation complex, leading to a reduction in gene transcription. This inhibition can cause widespread changes in gene expression patterns, impacting cellular processes that depend on the timely and regulated activation of transcription. These inhibitors provide valuable insights into the role of TAF II p170 in the regulation of gene expression and the broader dynamics of transcriptional control. By studying the effects of inhibiting TAF II p170, researchers can explore the complexities of transcriptional regulation and the essential components required for gene activation in eukaryotic cells.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$88.00
$200.00
13
(1)

Inhibits transcription by targeting RNA polymerase II, potentially affecting TAF15-mediated transcription.

Flavopiridol Hydrochloride

131740-09-5sc-207687
10 mg
$311.00
(2)

Cyclin-dependent kinase inhibitor, affecting transcription regulation and possibly influencing TAF15.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$42.00
$185.00
$310.00
$650.00
6
(1)

Inhibits RNA polymerase II phosphorylation, potentially impacting TAF15 function in transcription.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Interferes with DNA-dependent RNA synthesis, potentially affecting TAF15-mediated transcription.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

Inhibits RNA polymerase II, potentially altering transcription processes involving TAF15.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$226.00
$846.00
1
(0)

Inhibits BET family of bromodomain proteins, potentially influencing transcription factors including TAF15.

I-BET 151 Hydrochloride

1300031-49-5 (non HCl Salt)sc-391115
10 mg
$450.00
2
(0)

BET bromodomain inhibitor, could alter transcriptional regulation affecting TAF15's role.

Tozasertib

639089-54-6sc-358750
sc-358750A
25 mg
50 mg
$61.00
$85.00
4
(1)

Aurora kinase inhibitor, can indirectly affect transcriptional regulation and TAF15 function.

Rocaglamide

84573-16-0sc-203241
sc-203241A
sc-203241B
sc-203241C
sc-203241D
100 µg
1 mg
5 mg
10 mg
25 mg
$270.00
$465.00
$1607.00
$2448.00
$5239.00
4
(1)

Inhibits eukaryotic initiation factor 4A, indirectly affecting transcription and possibly TAF15.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$97.00
$254.00
36
(2)

Inhibits protein synthesis, potentially influencing cellular responses that include TAF15 activity.